Mylotarg
FDA Expands Use of Mylotarg to Infants at Least 1 Month Old
The FDA extended the indication for gemtuzumab ozogamicin (Mylotarg, Wyeth) to treat newly diagnosed CD33-positive ...
JUNE 19, 2020
FDA Approves Mylotarg for Newly Diagnosed AML
Gemtuzumab ozogamicin (Mylotarg, Pfizer) was approved for the treatment of adults with newly diagnosed ...
SEPTEMBER 5, 2017
Load more